Last reviewed 2026-04-23 · How we verify

Placebo trazodone and placebo Sentra PM

Targeted Medical Pharma · Phase 3 active Small molecule

Placebo trazodone and placebo Sentra PM is a Small molecule drug developed by Targeted Medical Pharma. It is currently in Phase 3 development for Control arm in Phase 3 clinical trial (active indications unknown without trial protocol).

This is a placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.

This is a placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials. Used for Control arm in Phase 3 clinical trial (active indications unknown without trial protocol).

At a glance

Generic name	Placebo trazodone and placebo Sentra PM
Sponsor	Targeted Medical Pharma
Modality	Small molecule
Therapeutic area	Psychiatry/Sleep Medicine
Phase	Phase 3

Mechanism of action

Placebo trazodone and placebo Sentra PM are inert formulations designed to match the appearance and administration of their active counterparts while containing no therapeutic agent. They are used in Phase 3 randomized controlled trials to establish efficacy and safety of the active drugs through comparison against a non-treatment control. The placebo effect itself may contribute to symptom improvement in some patients, which is why placebo controls are essential for determining true drug efficacy.

Approved indications

Control arm in Phase 3 clinical trial (active indications unknown without trial protocol)

Common side effects

No common side effects on file.

Key clinical trials

A Double-blind Placebo Controlled Trial of Sentra PM, a Medical Food (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Placebo trazodone and placebo Sentra PM CI brief — competitive landscape report
Placebo trazodone and placebo Sentra PM updates RSS · CI watch RSS
Targeted Medical Pharma portfolio CI

Frequently asked questions about Placebo trazodone and placebo Sentra PM

What is Placebo trazodone and placebo Sentra PM?

Placebo trazodone and placebo Sentra PM is a Small molecule drug developed by Targeted Medical Pharma, indicated for Control arm in Phase 3 clinical trial (active indications unknown without trial protocol).

How does Placebo trazodone and placebo Sentra PM work?

This is a placebo formulation containing no active pharmaceutical ingredient, used as a control in clinical trials.

What is Placebo trazodone and placebo Sentra PM used for?

Placebo trazodone and placebo Sentra PM is indicated for Control arm in Phase 3 clinical trial (active indications unknown without trial protocol).

Who makes Placebo trazodone and placebo Sentra PM?

Placebo trazodone and placebo Sentra PM is developed by Targeted Medical Pharma (see full Targeted Medical Pharma pipeline at /company/targeted-medical-pharma).

What development phase is Placebo trazodone and placebo Sentra PM in?

Placebo trazodone and placebo Sentra PM is in Phase 3.

Manufacturer: Targeted Medical Pharma — full pipeline
Therapeutic area: All drugs in Psychiatry/Sleep Medicine
Indication: Drugs for Control arm in Phase 3 clinical trial (active indications unknown without trial protocol)
Compare: Placebo trazodone and placebo Sentra PM vs similar drugs
Pricing: Placebo trazodone and placebo Sentra PM cost, discount & access